These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34619252)
1. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Zin Tun GS; Gleeson D; Al-Joudeh A; Dube A J Hepatol; 2022 Mar; 76(3):747-749. PubMed ID: 34619252 [No Abstract] [Full Text] [Related]
2. New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant? Zhou T; Fronhoffs F; Dold L; Strassburg CP; Weismüller TJ J Hepatol; 2022 Jan; 76(1):218-220. PubMed ID: 34450237 [No Abstract] [Full Text] [Related]
3. Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence. Garrido I; Lopes S; Simões MS; Liberal R; Lopes J; Carneiro F; Macedo G J Autoimmun; 2021 Dec; 125():102741. PubMed ID: 34717185 [TBL] [Abstract][Full Text] [Related]
4. Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine. Tao J; Rosenfeld D; Hsu J; Bhatia A Cutis; 2022 Mar; 109(3):148-149. PubMed ID: 35659140 [TBL] [Abstract][Full Text] [Related]
5. Herpes zoster reactivation after mRNA-1273 vaccination in patients with rheumatic diseases. Lee TJ; Lu CH; Hsieh SC Ann Rheum Dis; 2022 Apr; 81(4):595-597. PubMed ID: 34876461 [No Abstract] [Full Text] [Related]
6. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021. Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ; MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654 [TBL] [Abstract][Full Text] [Related]
7. Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years. Slomski A JAMA; 2022 Dec; 328(24):2388. PubMed ID: 36573976 [No Abstract] [Full Text] [Related]
8. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? Bril F; Al Diffalha S; Dean M; Fettig DM J Hepatol; 2021 Jul; 75(1):222-224. PubMed ID: 33862041 [No Abstract] [Full Text] [Related]
9. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Clayton-Chubb D; Schneider D; Freeman E; Kemp W; Roberts SK J Hepatol; 2021 Nov; 75(5):1249-1250. PubMed ID: 34171435 [No Abstract] [Full Text] [Related]
10. Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination. Wang SSY Indian J Tuberc; 2022 Jul; 69(3):369-370. PubMed ID: 35760490 [TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611 [TBL] [Abstract][Full Text] [Related]
12. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination. Joo CW; Kim YK; Park SP Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752 [TBL] [Abstract][Full Text] [Related]
13. Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons). Krychtiuk KA; Newby LK Ann Intern Med; 2022 May; 175(5):JC58. PubMed ID: 35500266 [TBL] [Abstract][Full Text] [Related]
14. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity? Kang SH; Kim MY; Cho MY; Baik SK J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965 [TBL] [Abstract][Full Text] [Related]
15. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A Front Immunol; 2021; 12():780594. PubMed ID: 34925359 [TBL] [Abstract][Full Text] [Related]
16. Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination. Shen X; Chalkias S; Feng J; Chen X; Zhou H; Marshall JC; Girard B; Tomassini JE; Aunins A; Das R; Montefiori DC N Engl J Med; 2022 Sep; 387(13):1234-1236. PubMed ID: 36083119 [No Abstract] [Full Text] [Related]
17. Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents. Ali K; Berman G; Zhou H; Deng W; Faughnan V; Coronado-Voges M; Ding B; Dooley J; Girard B; Hillebrand W; Pajon R; Miller JM; Leav B; McPhee R N Engl J Med; 2021 Dec; 385(24):2241-2251. PubMed ID: 34379915 [TBL] [Abstract][Full Text] [Related]
18. Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis. Martínez-Lapiscina EH; Lacruz F; Bolado-Concejo F; Rodríguez-Pérez I; Ayuso T; Garaigorta M; Urman JM Mult Scler; 2013 Aug; 19(9):1234-5. PubMed ID: 23069876 [No Abstract] [Full Text] [Related]
19. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine. Wang M; Wen W; Zhou M; Wang C; Feng ZH Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268 [No Abstract] [Full Text] [Related]
20. Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination. Won T; Gilotra NA; Wood MK; Hughes DM; Talor MV; Lovell J; Milstone AM; Steenbergen C; Čiháková D Front Immunol; 2022; 13():851620. PubMed ID: 35251049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]